Bioethical Considerations in Telehealth Enabled Clinical Trials, An Interdisciplinary Discussion

In connection with the American Telemedicine Association’s (ATA) Telehealth Awareness Week, partner Kyle Faget, co-chair of the firm’s Health Care Practice Group and co-chair of Foley’s Health Care & Life Sciences Sector’s Medical Device & Equipment Area of Focus, will be speaking on the ATA’s Therapeutics Lifecycle Special Interest Group’s panel “Bioethical Considerations in Telehealth Enabled Clinical Trials, An Interdisciplinary Discussion.”

The decentralized nature of telehealth enabled trials creates a different set of regulatory and ethical considerations compared to traditional, centralized trials. This expert panel will discuss these considerations from four different perspectives: clinical researcher, legal, bioethics professional, and participant/patient.

To view a recording of the webinar, click here.